Association of the Apolipoprotein B/Apolipoprotein A-I Ratio, Metabolic Syndrome Components, Total Cholesterol, and Low-Density Lipoprotein Cholesterol with Insulin Resistance in the Population of Georgia

Table 1

Descriptive characteristics between sexes.

	Pooled (𝑛=1522)	Female (𝑛=653; 43%)	Male (𝑛=869; 57%)	𝑃 value
Age	45±18	46±18	44±17	.023
ApoB/ApoA-I ratio	0.79±0.3	0.71±0.3	0.85±0.3	<.0001
ApoA-I (g/L)	1.06±0.42	1.07±0.39	1.06±0.44	<.0001
ApoB (g/L)	0.81±0.34	0.74±0.31	0.86±0.34	<.0001
SP (mmHg)	134±26	123±19	142±28	<.0001
DP (mmHg)	84±15	77±11	89±16	<.0001
WC (cm)	88±14	83±13	92±13	<.0001
BMI (kg/m^2)	27±7	25±5.5	28±7	<.0001
HDL-C (mmol/L)	1.28±0.3	1.41±0.2	1.19±0.2	<.0001
LDL-C (mmol/L)	2.92±0.7	2.74±0.5	3.06±0.7	<.0001
FG (mmol/L)	5.42±0.8	5.33±0.9	5.49±0.7	<.0001
FIns (𝜇U/mL)	14.66±10.5	13.75±11.17	15.35±9.94	<.0001
TG (mmol/L)	1.89±0.4	1.73±0.3	2.0±0.5	<.0001
TC (mmol/L)	4.70±0.8	4.46±0.7	4.88±0.8	<.0001
HOMA2-IR	1.57±0.50	1.87±1.36	2.04±1.24	<.0001
MetS 𝑛 (%)	552 (36.3)	190 (29.1)	362 (41.7)	<.0001
AH 𝑛 (%)	742 (48.8)	185 (28.3)	557 (64.1)	<.0001
Dyslipidemia 𝑛 (%)	783 (51.4)	265 (40.6)	518 (59.6)	<.0001

Data are expressed as mean ± SD.
The Mann-Whitney U test was used to compare the data between sexes.
Chi-square test was used to compare the prevalence of MetS, AH, and dyslipidemia between sexes.
ApoB/ApoA-I ratio: apolipoprotein B/apolipoprotein A-I ratio, ApoA-I: apolipoprotein A-I, ApoB: apolipoprotein B, SP: systolic blood pressure, DP: diastolic blood pressure, WC: waist circumference, BMI: body mass index, HDL-C: high-density lipoprotein cholesterol, LDL-C: low-density lipoprotein cholesterol, FG: fasting glucose, FIns: fasting insulin, TG: triglyceride, TC: total cholesterol, HOMA2-IR: homeostasis model assessment of insulin resistance, MetS: metabolic syndrome, and AH: arterial hypertension.